One Year in the Life of a Rapid Syndromic Panel for Meningitis/Encephalitis: a Pediatric Tertiary Care Facility's Experience
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Early establishment of infectious processes allows for expedited clinical management of meningitis and encephalitis. The FilmArray meningitis/encephalitis (FA-M/E) panel provides rapid detection of potential pathogens associated with encephalitis/meningitis in both immunocompetent and compromised patients. Here, we conducted a 1-year review of the performance of the FA-M/E panel at a tertiary care children's hospital. Two hundred sixty-five samples from 251 patients were tested. We found 87.25% (219/251) were negative, 9.96% (25/251) were positive for viral analytes, and 3.19% (8/251) were positive for bacterial analytes. When possible, positive results were confirmed by alternate testing; 4/6 available bacterial positives and 17/20 available viral positives were confirmed by retrospective culture or molecular testing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Leber, A. L., Everhart, K., Balada-Llasat, J.-M., Cullison, J., Daly, J., Holt, S., Lephart, P., Salimnia, H., Schreckenberger, P. C., DesJarlais, S., et al. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.00730-16 · Cited by 609 · cited 5×
“original presubmission study, two false-positive HSV-1 results were reported (2).”
BackgroundResultInfluentialSelf-citationCarvalho, M. D. G. S., Tondella, M. L., McCaustland, K., Weidlich, L., McGee, L., Mayer, L. W., Steigerwalt, A., Whaley, M., Facklam, R. R., Fields, B., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02498-06 · Cited by 588
Garges, H. P., Moody, M. A., Cotten, C. M., Smith, P. B., Tiffany, K. F., Lenfestey, R., Li, J. S., Fowler, V. G., & Benjamin, D. K. (2006) · Pediatrics · doi:10.1542/peds.2005-1132 · Cited by 351
Arora, H. S., Asmar, B. I., Salimnia, H., Agarwal, P., Chawla, S., & Abdel-Haq, N. (2017) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001551 · Cited by 66 · cited 1×
“Since FDA approval in October of 2015, the diagnostic utility of this assay has been highlighted in individual case reports (5, 6) and case series (7, 8).”
Wootton, S. H., Aguilera, E., Salazar, L., Hemmert, A. C., & Hasbun, R. (2016) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-016-0137-1 · Cited by 65
Gomez, C. A., Pinsky, B. A., Liu, A., & Banaei, N. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw245 · Cited by 53 · cited 1×
“As the first multiplex syndromic panel with indication for CSF testing, this panel has also been singled out for concerns regarding potential false positives (12), highlighting the extreme care needed in implementing proper molecular techniques to avoid cross contamination from the microbiome of personnel in contact w…”
BackgroundState-of-the-Art Microbiologic Testing for Community-Acquired Meningitis and Encephalitis
Polage, C. R., & Cohen, S. H. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.00289-16 · Cited by 43 · cited 1×
“However, the availability of this panel has quickly revolutionized the capabilities of laboratories with no molecular microbiology infrastructures and with one test offers the ability to detect multiple viral pathogens which would have represented individual send-out tests a year ago (3, 4).”
BackgroundLaunes, C., Casas-Alba, D., Fortuny, C., Valero-Rello, A., Cabrerizo, M., & Muñoz-Almagro, C. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.01931-16 · Cited by 26 · cited 1×
“Since FDA approval in October of 2015, the diagnostic utility of this assay has been highlighted in individual case reports (5, 6) and case series (7, 8).”
Research works printed but not linked: 17
- 10.1086/368191 · doi:10.1086/368191
- 10.1016/j.diagmicrobio.2016.05.020 · DOI · Paper page
- 10.1128/JCM.01159-16 · DOI · Paper page
- 10.1128/JCM.01957-16 · DOI
- 10.1016/j.diagmicrobio.2016.09.022 · DOI · Paper page
- 10.1016/j.diagmicrobio.2015.11.017 · DOI · Paper page
- 10.1128/JCM.01927-17 · DOI · Paper page
- 10.1515/cclm-2017-0518 · DOI
- 10.1093/ofid/ofx242 · DOI · Paper page
- 10.1097/INF.0b013e31817e519b · DOI
- 10.1086/338044 · DOI · Paper page
- 10.1097/INF.0000000000000112 · DOI
- 10.1016/j.diagmicrobio.2013.02.015 · DOI
- 10.1016/j.mimet.2011.10.021 · DOI
- 10.1542/peds.108.5.1169 · DOI · Paper page
- 10.1097/WCO.0000000000000085 · DOI
- 10.1136/archdischild-2012-301884 · DOI · Paper page
Cited by
Tansarli, G. S., & Chapin, K. C. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.11.016 · Cited by 263
Panels and syndromic testing in clinical microbiology
Dien Bard, J., & McElvania, E. (2020) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2020.08.001 · Cited by 92
Vetter, P., Schibler, M., Herrmann, J. L., & Boutolleau, D. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.12.013 · Cited by 64
Eichinger, A., Hagen, A., Meyer-Bühn, M., & Huebner, J. (2019) · Infection · doi:10.1007/s15010-018-1212-7 · Cited by 60
Pandey, U., Greninger, A. L., Levin, G. R., Jerome, K. R., Anand, V. C., & Dien Bard, J. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.00313-20 · Cited by 61
Self-citation
Metadata
- Authors
- Naccache, S. N., Lustestica, M., Fahit, M., Mestas, J., & Dien Bard, J.
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2018-05
- Volume
- 56
- Issue
- 5
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- OpenAlex
- W2790750882
- Cited by
- 59
- References
- 8
- FWCI
- 5.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: One Year in the Life of a Rapid Syndromic Panel for Meningitis/Encephalitis: a Pediatric Tertiary Care Facility's Experience. https://app.cochat.ai/papers/10.1128/jcm.01940-17
- The paper
- Naccache, S. N., Lustestica, M., Fahit, M., Mestas, J., & Dien Bard, J. (2018). One Year in the Life of a Rapid Syndromic Panel for Meningitis/Encephalitis: a Pediatric Tertiary Care Facility's Experience. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.01940-17
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.